Kite Pharma is a biotech company developing a pipeline of product candidates using its therapeutic platform: engineered Autologous Cell Therapy (eACT).
Tag Archives: Chimeric Antigen Receptor
Juno Therapeutics – next generation CAR technology
Juno Therapeutics is a biopharma company developing novel cellular immunotherapies based on two distinct and complementary platforms: T Cell Receptors (TCRs) and Chimeric Antigen Receptors (CARs) technologies.
Juno Therapeutics – next generation CAR technology
Cellectis – gene-editing
Cellectis is a biotech company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART).
Cellectis – gene-editing
